Friday, 18 February 2011

Red Biotechnology

Working to improve human health and lifestyle, using advances in technology and innovation.

In medicine, biotechnology has become an integral part in the diagnosis, gene therapy, clinical research and contract testing, therapeutic, bioactive, stem cells, genetic engineering and the development and production of new drugs to treat various diseases that are life threatening. The increased use of combination vaccines such as DPT with Hepatitis B, hepatitis A and polio vaccine injection, and several veterinary and poultry vaccines are examples of application of biotechnology in the field of drugs.

Tissue engineering, which deals with the plant tissue after culturing cells on biodegradable and biocompatible materials is the application of the new field with a great human development and alleviate human suffering. Besides the production of artificial leather, products of tissue engineering service contracts primarily through the provision of orthopedic cartilage, bone and intervertebral disc replacements.

Increasing application of biotechnology in the field of cancer research and treatment of disease, Parkinson's disease AM by discovering mutations and amplifications of a particular gene that causes Parkinson's disease AM is a revolution to open new frontiers to find a better and more effective treatment for the disease.

Biochips are also under development, as important tools for the development of personalized medicine. Biochips are miniaturized analytical tools that are used in diagnostics. They allow the rapid analysis of a patient's individual genetic OSA. Accelerating the development of new drugs, to allow early detection of disease, dose adjustment of medications to patients, AO individual needs and thereby reducing the number of unwanted side effects

It 'also known that some substances are only effective in some patients because of their particular genetic predisposition. Scientific studies have shown that the anti-cancer drug is effective in only about 10 percent of all cancer patients. E 'genetically possible to determine whether a particular patient belongs to the group of patients for whom the drug is effective. Another study showed that patients react differently to different doses of anti-depression and beta-blockers to control hypertension by maintaining their level of metabolism and genetic predisposition. Molecular genetics has shown that it is possible to determine the best medication dosage or can specify whether a particular drug is effective. This is, of course, also possible to design drugs based on specific genetic groups of specific patients. All this leads to a huge potential application of research and industry for a market that is growing.

Needless to say that biotechnology has a great demand for red, not only for growth in the sector, but is also useful to use technology more charitable to relieve human suffering and improve quality of life.